Introduction {#s0001}
============

Generalised anxiety disorder (GAD) is common among people living with HIV (PLWH).^[@CIT0001],[@CIT0002],[@CIT0003]^ GAD is highly impairing and is associated with poor quality of life and low levels of adherence to HIV treatment.^[@CIT0004],[@CIT0005]^ Yet, using diagnostic interviews to identify cases of mental disorders, including GAD, is often cost and resource intensive. Moreover, there are insufficient healthcare professionals in the public health systems in resource-constrained countries such as South Africa who possess the necessary knowledge and skills required to diagnose GAD.^[@CIT0006]^ Therefore, screening may be necessary to identify individuals with GAD in these environments. We sought to evaluate the effectiveness of the Beck anxiety inventory (BAI) in detecting GAD among people seeking HIV testing. Successful case identification will enhance the likelihood of persons who need treatment.

The ability of screening instruments to discriminate between GAD cases and non-cases is usually assessed in terms of the optimal combination of sensitivity and specificity.^[@CIT0007],[@CIT0008]^ Sensitivity refers to the ability of the screening instrument to accurately detect individuals with the disorder.^[@CIT0007],[@CIT0008]^ A screening instrument with poor sensitivity will miss a large number of individuals who meet the diagnostic criteria for the disorder, yielding a large number of false negative results. Specificity, on the other hand, refers to the ability of the screening instrument to accurately detect individuals without the disorder.^[@CIT0007],[@CIT0008]^ A screening instrument with poor specificity will positively identify a large number of individuals who do not meet the diagnostic criteria for the disorder, yielding many false positives.

Screening instruments, compared to structured interviews, are short, easy to use and require minimal training for test administrators. The major disadvantage of screening, however, is the possibility of yielding large numbers of false positive and false negative cases.^[@CIT0009]^ Over-identification of GAD can lead to an added financial burden on the healthcare system in resource-constrained communities, as false positive cases may be unnecessarily referred for treatment.^[@CIT0010]^

Generalised anxiety disorder and HIV {#s20002}
------------------------------------

The prevalence of GAD among people living with HIV varies widely, depending on the methods of assessment used, that is, structured diagnostic interviews and self-report measures. For example, using the MINI international neuropsychiatric interview (MINI), 13.3% of 649 HIV-infected individuals in Zambia met the diagnostic criteria for GAD.^[@CIT0011]^ Similarly, Adewuya et al.^[@CIT0001]^ reported that 11.4% of 88 Nigerian HIV-infected individuals met the diagnostic criteria for GAD using the MINI. However, among 456 HIV-positive patients in South Africa, the prevalence of GAD as assessed by the MINI was 4.6%.^[@CIT0002]^ An even lower rate of GAD of 0.4% was found among 900 HIV-positive individuals using the Composite International Diagnostic Interview (CIDI).^[@CIT0003]^ As treatment for HIV has become more accessible in recent years, a diagnosis of HIV has become less life-threatening, which may explain the lower rates of symptoms of anxiety among HIV-infected individuals.^[@CIT0012]^ Even though the prevalence of GAD has been documented among persons living with HIV, we were only able to find one study among individuals seeking an HIV test. In Goa, India, 1.1% of 1874 persons receiving HIV testing reported elevated symptoms of anxiety using the 7-item generalised anxiety scale (GAD-7).^[@CIT0013]^

The aim of this study was to determine the prevalence of GAD caseness and sub-threshold anxiety symptoms among persons seeking an HIV test. We also sought to assess the effectiveness of the BAI in discriminating between those who met the criteria for GAD and those who did not. These data were collected as part of a PhD thesis.^[@CIT0014]^

Method {#s0003}
======

Participants {#s20004}
------------

Five hundred participants were enrolled in the study by means of convenience sampling before undergoing HIV testing at five HIV testing sites in the Western Cape region of South Africa. HIV testing is conducted under the auspices of the Western Cape Department of Health and outsourced to testing sites. Personnel at the testing site set up temporary structures in open public spaces in the community, such as the parking lots of shopping centres or taxi ranks. All persons seeking an HIV test who were conversant in English were eligible to participate in the study and non-English (*n* = 40) speaking participants were excluded from the study.

Procedures {#s20005}
----------

At the clinic reception, HIV test seekers were handed a flyer that described the study. They were then invited to meet with a researcher in a private room. Those participants who agreed were informed about the study in more detail and were invited to participate.

Measures {#s20006}
--------

### Generalised anxiety disorder {#s30007}

We used the Structured Clinical Interview for the DSM-5 (SCID-5- Research Version) to determine caseness for GAD. The SCID-5 has been used as the 'gold standard' in several studies to ascertain the presence of clinical disorders^[@CIT0015],[@CIT0016]^ and is anchored to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). The SCID was chosen as the gold standard instead of the MINI and CIDI because it adheres more strictly to the DSM 5 diagnostic criteria. Also, while the MINI is short and brief, it only provides a diagnosis at a single time point,^[@CIT0017],[@CIT0018]^ whereas the SCID provides current and past diagnoses of mental health disorders,^[@CIT0019]^ which were also assessed in this study.

We conducted a pilot study to assess whether the participants understood the questions on the SCID. The results indicated that the SCID questions would be comprehensible among the sample. Data collectors received intensive training in administration of the SCID to ensure that they kept their responses to interview items as consistent as possible and quality checks were conducted to ensure fidelity to the SCID interview schedule. The SCID questions were set up on a web-based platform and the responses were captured on a Lenovo tablet.

### Symptoms of anxiety {#s30008}

The 21-item BAI assesses the severity of anxiety in patients with psychiatric disorders^[@CIT0020]^ with a total score ranging between 0 and 63.^[@CIT0020],[@CIT0021]^ Notably, the BAI assesses symptoms of anxiety in the past 2 weeks and not acute anxiety (i.e., anxiety at the time of undergoing HIV testing). The BAI has a four-point Likert-type scale which ranges from 0 ('not at all') to 3 ('severely' -- I could barely stand it).^[@CIT0020]^ A total score of between 0 and 7 on the BAI indicates minimal anxiety, 8--15 indicates mild anxiety, 16--25 indicates moderate anxiety and between 26 and 63 indicates severe anxiety.^[@CIT0020],[@CIT0021]^ The BAI has consistently shown high internal consistency (e.g., Cronbach's alpha = 0.92;^[@CIT0020]^), including among South African samples.^[@CIT0022],[@CIT0012]^ For example, the Cronbach's alpha of a Xhosa version of the BAI was 0.92, indicating high internal consistency.^[@CIT0021]^ In an exploratory factor analysis among 101 HIV-positive individuals in South Africa receiving ART, a single factor structure accounted for 68.7% of the variance among the items.^[@CIT0012]^

Ethical considerations {#s20009}
----------------------

The study obtained ethical approval from the Stellenbosch University Health Ethics Committee (N13/05/062). An informed consent form was signed by all participants. Those participants who were found to be psychologically distressed or being diagnosed with a psychiatric disorder were referred to a nearby mental health facility for further services.

Results {#s0010}
=======

Sample demographic characteristics {#s20011}
----------------------------------

We recruited 540 participants including 40 participants who were ineligible because they could not understand English. Consequently, as can be seen in [Table 1](#T0001){ref-type="table"}, the total sample consisted of 500 participants of which 51.6% identified as women, and 48.4% as men. The mean age of the participants was 36 years. A total of 98.8% of participants were from historically disadvantaged groups, that is, they self-identified as black or mixed race people. The majority of the sample (69.0%) were Afrikaans-speaking individuals, while 6.0% were English-speaking and 19.6% were isiXhosa-speaking individuals.

###### 

Sample demographic characteristics.

  Characteristics              *N*   \%     95%CI
  ---------------------------- ----- ------ --------------
  **Gender**                                
  Male                         242   48.4   44.02--52.78
  Female                       258   51.6   47.22--55.98
  **Age (years)**                           
  Mean                         \-    36     \-
  18--19                       27    5.4    3.42--7.38
  20--29                       150   30.0   25.98--34.02
  30--39                       139   27.9   23.97--31.83
  40--49                       102   20.5   16.96--24.04
  50--71                       80    15.9   12.69--19.11
  **Race**                                  
  Black                        131   26.2   22.35--30.05
  Mixed race                   363   72.6   68.69--76.51
  White                        4     0.8    0.02--1.58
  Other                        2     0.4    −0.15--0.95
  **First language**                        
  Afrikaans                    345   69.0   64.95--73.05
  English                      30    6.0    3.92--8.08
  isiXhosa                     98    19.6   16.12--23.08
  Other                        27    5.4    3.42--7.38
  **Current work situation**                
  Employed full-time           97    19.4   15.93--22.87
  Employed part-time           106   21.2   17.62--24.78
  Unemployed                   233   46.6   42.23--50.97
  Homemaker                    11    2.2    0.91--3.49
  Student                      29    5.8    3.75--7.85
  Disabled                     7     1.4    0.37--2.43
  Retired                      17    3.4    1.81--4.99

*N*, sample size; %, percentage; 95% CI, 95% confidence interval.

Generalised anxiety disorder and symptoms of anxiety {#s20012}
----------------------------------------------------

The prevalence of GAD among our sample was 3.4% (*n* = 17) while 96.6% (*n* = 483) did not have GAD. The internal consistency as measured by Cronbach's alpha for the BAI was excellent (0.94). The mean score of 12.58 on the BAI fell in the range of minimal anxiety. As can be seen in [Table 2](#T0002){ref-type="table"}, 78.2% of the sample reported minimal anxiety, 13.6% reported moderate anxiety and 8.2% reported severe anxiety.

###### 

Percentage of sample in each Beck anxiety inventory category.

  BAI category                *N*   \%      95%CI
  --------------------------- ----- ------- --------------
  Mild anxiety (0--21)        391   78.20   74.58--81.82
  Moderate anxiety (22--35)   68    13.60   10.6--16.6
  Severe anxiety (36--63)     41    8.20    5.8--10.6

*N*, sample size; %, percentage; 95% CI, 95% confidence interval; BAI, Beck anxiety inventory.

Receiver operating characteristic analysis for generalised anxiety disorder {#s20013}
---------------------------------------------------------------------------

The receiver operating characteristic (ROC) curve in [Figure 1](#F0001){ref-type="fig"} shows the performance of the BAI in correctly identifying GAD. The area under the curve (AUC) of 86% (AUC = 0.86) indicates that the BAI is moderately accurate in determining cases of GAD.

![Area under the curve.](SAJPsy-25-1336-g001){#F0001}

[Table 3](#T0003){ref-type="table"} shows the optimal cut-off point of 21.5, which yielded the optimal combination of sensitivity (0.82) and specificity (0.80).

###### 

ROC curve coordinates of the Beck anxiety inventory using the SCID as the gold standard.

  Cut-off point   Sensitivity   1-Specificity   Specificity
  --------------- ------------- --------------- -------------
  1.0000          1.000         1.000           0.000
  0.5000          1.000         0.874           0.126
  1.5000          1.000         0.805           0.195
  2.5000          0.941         0.735           0.265
  3.5000          0.941         0.692           0.308
  4.5000          0.941         0.627           0.373
  5.5000          0.941         0.590           0.410
  6.5000          0.941         0.538           0.462
  7.5000          0.941         0.497           0.503
  8.5000          0.882         0.470           0.530
  9.5000          0.882         0.435           0.565
  10.5000         0.882         0.414           0.586
  11.5000         0.882         0.383           0.617
  12.5000         0.882         0.356           0.644
  13.5000         0.882         0.335           0.665
  14.5000         0.882         0.311           0.689
  15.5000         0.882         0.288           0.712
  16.5000         0.882         0.271           0.729
  17.5000         0.824         0.253           0.747
  18.5000         0.824         0.238           0.762
  19.5000         0.824         0.222           0.778
  20.5000         0.824         0.213           0.787
                                                
  **21.5000**     **0.824**     **0.197**       **0.803**

ROC, receiver operating characteristic; BAI, Beck anxiety inventory; SCID, structured clinical interview for the DSM-5.

Note: The row in bold indicates the optimal cut-off point which yielded optimal sensitivity and specificity.

As can be seen in [Table 4](#T0004){ref-type="table"}, 17 participants (3.4%) out of the total sample (*n* = 500) were diagnosed with GAD using the SCID. Of these 17 participants, 14 (82.4%) participants scored above 21.5 on the BAI and met the diagnostic criteria for GAD using the SCID, that is, they were true positives. However, of the 17 participants, 3 (17.6%) participants scored below 21.5 on the BAI but met the diagnostic criteria for GAD using the SCID, that is, they were false negatives.

###### 

Two-by-two table of BAI versus structured clinical interview generalised anxiety disorder diagnosis.

  BAI cut-off score   Positive (SCID)      *n*              Negative (SCID)       *n*               Total
  ------------------- -------------------- ---------------- --------------------- ----------------- -------------
  BAI ≥ 21.5          14 (true positive)   a                97 (false positive)   c                 a + c = 111
  BAI \< 21.5         3 (false negative)   b                386 (true negative)   d                 b + d = 389
                                                                                                    
  **Total**           **-**                **a + b = 17**   **-**                 **c + d = 483**   **-**

*n*, sample size; BAI, Beck anxiety inventory; SCID, structured clinical interview for the DSM-5.

Conversely, 483 (96.6%) participants of the total sample were not diagnosed with GAD using the SCID. Of these 483 participants, 97 participants (20.1%) scored above 21.5 on the BAI but did not meet the diagnostic criteria for GAD using the SCID, that is they were false positives.

Of the 483 participants, 386 (80.0%) participants scored below 21.5 on the BAI and did not meet the diagnostic criteria for GAD on the SCID, that is they were true negatives.

As can be seen in [Table 5](#T0005){ref-type="table"}, the positive predictive value (PPV) was 13.0% and the negative predictive value (NPV) was 99.2%. These data indicate a 13.0% probability that individuals who scored above 21.5 would meet the diagnostic criteria for GAD, and a 99.2% probability that individuals who scored below 21.5 would not meet the criteria for the disorder.

###### 

Sensitivity, specificity and predictive values of the Beck anxiety inventory with reference to the optimal cut-off point of 21.5.

  Test characteristics              Formula   Expression   Value   \%      95% CI
  --------------------------------- --------- ------------ ------- ------- ---------------
  Sensitivity                       a/(a+b)   14/17        0.82    82.35   79.01--85.69
  Specificity                       d/(c+d)   386/483      0.80    80.00   76.49--83.51
  Positive predictive value (PPV)   a/(a+c)   14/111       0.13    13.00   10.05--15.95
  Negative predictive value (NPV)   d/(b+d)   386/389      0.99    99.23   98.46--100.00

95% CI, 95% confidence interval.

Discussion {#s0014}
==========

Among our sample, the prevalence of GAD was 3.4%. Olley, Seedat and Stein^[@CIT0023]^ found higher GAD rates among HIV-positive individuals at both baseline (6.7%) and at 6-month follow-up (6.2%) visits, compared to the current study of 3.4%. Yet, among 900 HIV-positive South Africans the prevalence of GAD was 0.4%.^[@CIT0003]^ The differences in prevalence rates may be attributed to the discrepancies in the measuring instruments used (i.e., MINI and CIDI), compared to the current study which used the SCID as well as the nature of the sample (i.e., persons receiving HIV testing rather than those living with HIV).

The mean total score (12.58) of the BAI fell in the range of minimal anxiety. However, a minority (13.6%) of the sample scored in the moderate to severe range, suggesting that anxiety was a concern for these individuals. For this group, it was possible that anxiety may have been due to the prospect of undergoing an HIV test, a finding that is in keeping with previous research that found elevated levels of anxiety (19.5%) among South Africans living with HIV.^[@CIT0012]^

As a screening tool, the BAI performed well in discriminating between GAD caseness and non-caseness (AUC = 0.86), and indicated it has moderately high accuracy in identifying GAD.^[@CIT0024]^ The cut-off point of 21.5 yielded optimal sensitivity (82.4%) and specificity (80.0%) values, indicating that this cut-off point may be suitable in discriminating between GAD cases and non-cases among HIV test seekers.

Using the cut-off point of 21.5, the BAI yielded a low PPV (13.0%) in identifying GAD, suggesting a 13.0% probability that individuals with a positive test would be diagnosed with GAD. The PPV is dependent on the prevalence estimate of the underlying condition or disorder, in this case GAD.^[@CIT0007],[@CIT0008]^ As the prevalence of GAD was low in the sample, the PPV was also low. On the other hand, the NPV was 99.2%, suggesting a 99.2% probability that individuals with a negative test would be identified as not having GAD. It appears therefore that the BAI is highly successful at predicting non-caseness but less successful at predicting caseness for GAD given its low prevalence.

Although those individuals who screen positive for GAD may benefit from referral to treatment, a positive screen on its own is likely to be inadequate to yield a diagnosis of a psychiatric disorder.^[@CIT0010]^ Given our data, it is recommended that persons who score above the cut-off point of the BAI undergo a follow-up assessment with a diagnostic interview such as the SCID to confirm a diagnosis of GAD.^[@CIT0025]^

Limitations of the study {#s20015}
------------------------

A limitation of this study is that we recruited participants from HIV testing sites in the Western Cape only, which limits the generalisability of the study. Another limitation is that a convenience rather than a random sample was used consisting of persons seeking HIV testing.

The current study design does not include a control group, which makes it impossible to compare the prevalence of GAD among our sample with a comparison group of individuals not seeking HIV testing. However, it is necessary to note that the aim of this article was to report on the psychometric properties of the BAI and not to make definitive statements about the prevalence of anxiety. Further, the SCID and self-report questionnaires were not translated to Afrikaans and isiXhosa because of limited resources and time and thus only English-speaking participants were included in the study.

Conclusion {#s0016}
==========

Our findings demonstrate that the BAI may be used to screen for anxiety among HIV test seekers in South Africa. Nonetheless, a two-tiered approach is recommended to improve the problem of over-detection. In settings where resources are limited, the BAI may assist with the identification of those individuals in need of follow-up assessment and referrals for mental health treatment prior to or in conjunction with receipt of an HIV test result. In terms of further research, it is necessary to develop effective screening instruments and procedures that are more appropriate and feasible to implement in local settings, including among non-English speaking participants.

This article is based on the thesis (PhD) of the first author at the University of Stellenbosch, 2017, titled 'Common mental and substance disorders among people seeking HIV testing' by Dr Wylene Saal under the supervision of Prof. Ashraf Kagee, available here: <https://scholar.sun.ac.za/>.
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